Showing results (211-220 of 248) with videos related to
Sort By:
Pageof 25
Advances in Therapy|January 28, 2021
Benefit of Early Add-on of Linagliptin to Insulin in Japanese Patients With Type 2 Diabetes Mellitus: Randomized-Controlled Open-Label Trial (TRUST2)Tomoyuki Katsuno, Toshihiko Shiraiwa, Shingo Iwasaki, et al.Muscle & Nerve|July 18, 2013
Triple A syndrome in JapanMasanori Ikeda, Makito Hirano, Keiich Shinoda, et al.Leukemia & Lymphoma|March 11, 2010
Antifungal prophylaxis with micafungin in neutropenic patients with hematological malignanciesYuji Hirata, Taiji Yokote, Kichinosuke Kobayashi, et al.Journal of Diabetes Investigation|May 21, 2014
Report of the Committee of the Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus: New diagnostic criteria of fulminant type 1 diabetes mellitus (2012)Akihisa Imagawa, Toshiaki Hanafusa, Takuya Awata, et al.Journal of Diabetes Investigation|May 21, 2014
Diagnostic criteria for acute-onset type 1 diabetes mellitus (2012): Report of the Committee of Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes MellitusEiji Kawasaki, Taro Maruyama, Akihisa Imagawa, et al.Diabetes|March 28, 2002
Thyroid hormone receptor interacting protein 3 (trip3) is a novel coactivator of hepatocyte nuclear factor-4alphaHiromi Iwahashi, Kazuya Yamagata, Issei Yoshiuchi, et al.Plos One|May 14, 2016
Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in JapanJunichi Yasui, Eiji Kawasaki, Shoichiro Tanaka, et al.Journal of the Neurological Sciences|July 15, 2014
Tracheostomy and invasive ventilation in Japanese ALS patients: decision-making and survival analysis: 1990-2010Muneyoshi Tagami, Fumiharu Kimura, Hideto Nakajima, et al.Diabetology International|January 4, 2019
Clinical features of cases of seroconversion of anti-glutamic acid decarboxylase antibody during the clinical course of type 2 diabetes: a nationwide survey in JapanYoichi Oikawa, Akira Shimada, Takuya Awata, et al.Diabetes|January 5, 2002
Overexpression of dominant-negative mutant hepatocyte nuclear fctor-1 alpha in pancreatic beta-cells causes abnormal islet architecture with decreased expression of E-cadherin, reduced beta-cell proliferation, and diabetesKazuya Yamagata, Takao Nammo, Makoto Moriwaki, et al.Pageof 25